NCT06473545

Brief Summary

Guided bone regeneration (GBR) is a commonly performed technique, using autogenous grafts, allografts, xenografts, or synthetic bone grafts (SBG). Advantages of an "off the shelf" substitute, available anytime with limitless fabrication capacity that avoids human, or animal associated morbidity provides SBG with a very positive future perspective. This data collection is to retrospectively evaluate the long-term clinical performance of a CE marked biomimetic SBG substitute in patients with implant placement related bone regeneration treatments up to 72 months of follow-up. The study hypothesis states that a biomimetic SBG is a verified graft choice to be used clinically in patients with implant placement related bone regeneration treatments such as socket preservation with a delayed implant placement, GBR simultaneous with immediate implant placement, and sinus lift elevation with lateral approach.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
173

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Apr 2023

Shorter than P25 for all trials

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2023

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 20, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 20, 2023

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

June 13, 2024

Completed
12 days until next milestone

First Posted

Study publicly available on registry

June 25, 2024

Completed
Last Updated

June 25, 2024

Status Verified

June 1, 2024

Enrollment Period

9 months

First QC Date

June 13, 2024

Last Update Submit

June 19, 2024

Conditions

Keywords

Bone graftImplant PlacementImmediate implant placementSocket preservationGuided bone regenerationSynthetic bone graftDelayed implant placementSinus elevation

Outcome Measures

Primary Outcomes (2)

  • Implant survival

    Implant in place at any follow up visit

    From final prosthesis delivery through study completion, up to 72 months.

  • Prosthesis survival

    Prosthesis survival at any follow up visit

    From final prosthesis delivery through study completion, up to 72 months.

Secondary Outcomes (3)

  • Complications

    From initial surgical procedure date (GBR or implant placement) through study completion, up to 72 months

  • Peri-implant evaluation, marginal bone loss

    From final prosthesis delivery through study completion, up to 72 months.

  • Peri-implant evaluation, soft tissue evaluation PES-WES score

    From final prosthesis delivery through study completion, up to 72 months.

Study Arms (4)

Socket Preservation

Socket preservation is completed at the time of extraction. After removal of the tooth, the gum is elevated away from the bone, the socket is thoroughly cleansed, the socket is packed with the SBG and the wound closed. A healing time between 3 to 9 months is .

Immediate implant placement

Implant placement immediately after tooth extraction, the bone grafting material is packed between the implant and the bone wall.

Guided bone regeneration

When ridge augmentation is indicated, guided bone regeneration with the SBG and a barrier membrane are utilized at the time of tooth extraction or at an edentulous bone ridge. Either simultaneous implant placement or delayed implant placement are performed at the time of GBR surgery or after a 4 to 9 months healing time respectively.

Sinus elevation

Schneiderian membrane elevation to increase the residual crestal bone height in the posterior maxilla, bone grafting material is placed into the newly created space, including elevation through the lateral approach.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Community population attending to one of the centers adhered to the study.

You may qualify if:

  • The subject was at least 18 years of age (or age of consent) and has finalized skeletal growth at the time of surgery.
  • Patient was in need of one or multiple tooth replacements.
  • Treatment using synthetic bone graft was done for implant placement either in IIP or DIP.

You may not qualify if:

  • Previous bone augmentation procedures with a different treatment choice (lateral or vertical regeneration).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Clínica Dental Altes Mesquida

Palma de Mallorca, Balearic Islands, 07004, Spain

Location

Cairó Franch Clinica Dental

Barbera Del Valles, Barcelona, 08210, Spain

Location

MeSH Terms

Conditions

Tooth LossTooth Fractures

Condition Hierarchy (Ancestors)

Periodontal DiseasesMouth DiseasesStomatognathic DiseasesTooth DiseasesTooth InjuriesWounds and Injuries

Study Officials

  • Juan Mesquida, DDS

    International Dentistry Research Group Clinical Director

    PRINCIPAL INVESTIGATOR
  • Ignacio Ginebreda, DDS

    International Dentistry Research Group co-Clinical Director

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 13, 2024

First Posted

June 25, 2024

Study Start

April 1, 2023

Primary Completion

December 20, 2023

Study Completion

December 20, 2023

Last Updated

June 25, 2024

Record last verified: 2024-06

Locations